Project Grant HT9425261E064
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $3.3M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75208, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $3.16 million in project grant funding under the Military Medical Research and Development program (CFDA 12.420) to Eg427 for a First-in-Human (FIH) Phase 1B/2A dose escalation clinical trial. The award, effective July 1, 2025, through June 30, 2028, supports research and development services focused on EG110A, a nonreplicative herpes simplex virus 1 (HSV-1) derived gene therapy administered via intradetrusor injection. The...
- Federal Project Grant Award Summary Emory University received a $3.13 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded May 1, 2025, with a completion date of April 30, 2029. The award supports therapeutic research focused on the development and application of human induced pluripotent stem cell-derived lymphatic endothelial cells for treating lymphedema. This four-year research initiative will be...
- The Defense Health Agency awarded Epicentrx Inc. a $385,536 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports the development and translation of a multimodal therapeutic agent and medical countermeasure for the treatment of military-related toxic exposures. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The research aims to transform healthcare for military service members and...
- The Defense Health Agency awarded a $4,288,290 Project Grant to Eliksa Therapeutics, Inc. of Doylestown, PA under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel ophthalmic solution to treat the ocular manifestations of epidermolysis bullosa, a rare and debilitating genetic skin disorder. The funding will enable Eliksa Therapeutics to conduct research and clinical trials over a 2-year period from July 1, 2024 to June 30, 2026,...
- This federal Project Grant award of $2,070,414, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on mesenchymal stem cell extracellular vesicle therapies for epidermolysis bullosa at the University of Miami. The research project aims to transform healthcare for military service members, veterans, and the broader public by developing innovative diagnostic tools, therapeutic interventions, and...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $156,049 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025, through September 30, 2026. The project, titled "Establishing Epigenetic Markers in Neurofibromatosis," supports biomedical research designed to advance innovative medical solutions for military service members and the American public....
- Federal Project Grant Award Summary The Feinstein Institutes For Medical Research received a $299,991 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025, through September 30, 2027. The award funds research investigating the proinflammatory function and heterogeneity of age-associated B cells in systemic lupus erythematosus (SLE). This hypothesis-driven research initiative will be conducted at...
- The Defense Health Agency awarded a $293,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Medical Research, Infrastructure And Health Services Fund Of The Tel Aviv Medical Center in Israel. The grant, awarded on April 1, 2025, supports a research project investigating "Clinical Variation in Epidermolysis Bullosa: A New Layer of Complexity and a New Opportunity for Understanding Wound Healing." This specialized medical research project...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $626,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with a completion date of July 14, 2027. The award funds research focused on developing immune-competent three-dimensional (3D) bioprinted organoids designed to study and overcome barriers to cellular therapy for neuroblastoma treatment. This two-year...
- Federal Grant Award Summary Memsel Inc. received a $4.52M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with a completion date of August 31, 2027. The grant funds the development of advanced wound care solutions specifically designed to address multi-drug resistant infections and hemorrhage control in battlefield conditions. The research and development initiative leverages Memsel Inc.'s core...